UNSPSC 51172440: Bismuth subcarbonate/kaolin/opium/pectin

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class GA208. This VA Drug Class (GA208) classifies this compound as belonging to the group ANTIDIARRHEAL AGENTS.

UNSPSC 51172440 Bismuth subcarbonate/kaolin/opium/pectin is a Commodity code that nominally describes antidiarrheal pharmaceutical compounds, but recent state and local solicitations show minimal activity directly aligned with this specific product classification. The recent opportunities block contains three postings: one from Collin County for offender drug-testing services (specimen collection, lab screening, and confirmation testing), one from Texas HHS for direct-to-manufacturer prescription capabilities (an exploratory RFI), and one from the Minnesota Multistate Cooperative Purchasing Alliance for generic pharmaceuticals and OTC products across multiple wholesaler channels. Only the MMCAP opportunity touches pharmaceutical procurement broadly; the others address testing services and pharmacy benefit program design rather than antidiarrheal compounds or the ingredients this code names. The issuing bodies span county criminal-justice departments, state health agencies, and cooperative purchasing consortia, reflecting fragmentation across multiple procurement channels and use cases.

Recent activity appears concentrated in Texas and Minnesota. The Collin County RFP (2026-327, due July 23, 2026, estimated value $600,000) focuses on drug-testing operations for community supervision with a two-year term and optional three one-year renewals, funded by the Texas Department of Criminal Justice. The Texas HHS RFI (HHS0017013, posted April 3, 2026) sought vendor input on direct-to-manufacturer pharmacy contracting but contains no award value or formal evaluation criteria—it functions as market research rather than a binding solicitation. The MMCAP RFP (S1070000015802, due March 26, 2026) addresses generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers across Minnesota, Oregon, and participating jurisdictions, with a two-year initial term and optional extensions through June 30, 2028; no specific award values are disclosed, but vendors must pay a 3 percent administrative fee and comply with performance penalties. The code shows little recent state and local activity specifically targeting bismuth subcarbonate, kaolin, opium, or pectin formulations; the pharmaceutical opportunities posted are broader in scope and do not align tightly with the commodity's nominal scope.